Millennium Appoints Six Scientists to Board

CAMBRIDGE, Mass.--Millennium Pharmaceuticals here has appointed six scientists to its scientific advisory board, including Chairman Christopher Walsh, Frank Austen, Gerald Fink, Raju Kucherlapati, Eric Lander, and Harvey Lodish. Mark Levin, Millennium's CEO, commented, "The expertise of these six scientific leaders will further drive Millennium's high-throughput drug discovery platform towards our goal of creating therapeutic products." Millennium is a drug discovery company that makes widespread use of bioinformatics.